260 Comments

Hello?! Ivermectin! A Merck created drug that no longer makes them money and looks to have better efficacy than whatever this is going to be. I find this disgusting.

Expand full comment

This is what I thought when I read about this. Ivermectin already exists and we know it's safe. I am repulsed by our government (except Sen. Ron Johnson, Rand Paul and a few others) and the medical establishment. Dr. Pierre Kory testified to congress about Ivermectin 10 months ago.

Expand full comment

Let Big Pharma come out with their "miracle" pills if this means the Vaccine Cult gets put on the ash heap of Covid history !! Remember , These vaccines received EUA only because "supposedly" there was no alternative effective treatments. By definition, these new "pills" should end the Vaccine mandates if it's really all about Public Health; We'll know the truth soon enough!!!

Expand full comment

Demonizing, denying or just not offering treatment to hundreds of thousands, maybe tens of millions of people from day 1 is medical malpractice, intentional manslaughter, inhuman and immoral!

https://rescue.substack.com/p/how-ivermectin-saved-louis-gossett?r=nxypy&utm_campaign=post&utm_medium=email&utm_source=

Expand full comment

Yes, I wonder if this "new" drug is just a retread of IVM to get them another 6 years of exclusivity.

Expand full comment

I had the exact same thought....

Expand full comment

That is what I would suspect too! But EUA should end too!

Expand full comment

EUA for JNJ and mRNA should’ve ended as soon as Pfizer was rubber stamped. I mean “approved”. 🙄 In fact, there has never been an emergency for anyone healthy & under 75. These drugs should NEVER have been under EUA for the general population (EUA has never been used in that way before), and it absolutely should not be given it to kid, including college kids.

Expand full comment

I suspect that it is.

Expand full comment

Damn, Molnupiravir is almost as effective as That Drug That Saved Uttar Pradesh from COVID19. Which costs about $30. Gosh, why doesn't FDA like a drug like that? Let me think. Aduhelm was $56,000, and they sure liked that. Even though the Aduhelm trial was stopped early "due to futility." And this new drug - Molnupiravir - it will cost $700. Uncle Sam has already bought it. So FDA will for sure like that one too. But that India-Saving-Drug? The $30 thing. What do they call it again? "The Drug That Will Never Be Approved." Because it is off-patent. And nobody makes money from it.

https://journals.lww.com/americantherapeutics/Fulltext/2021/08000/Ivermectin_for_Prevention_and_Treatment_of.7.aspx

But three cheers for Molnupiravir. Yay. Pharma (and their captured pals at FDA) stuffed approval of anything that looked like it might work (including vitamin D!) to retain "space" for the EUA for this monster. Can't have an EUA if there's already a treatment. Like, say, Ivermectin.

Expand full comment

Let Big Pharma come out with their "miracle" pills if this means the Vaccine Cult gets put on the ash heap of Covid history !! Remember , These vaccines received EUA only because "supposedly" there was no alternative effective treatments. By definition, these new "pills" should end the Vaccine mandates if it's really all about Public Health; We'll know the truth soon enough!!!

Expand full comment

Talk about a poison pill but maybe they will back off the poison dart with this “wonder” drug. Who knows maybe it will even win a Nobel prize?

Expand full comment

I believe that Merck also makes another drug that is effective for treating and even preventing Covid-19. I believe it rhymes with "driver pectin."

Expand full comment

I LOVE pectin.

Expand full comment

Bahahahahaha!

Expand full comment

Yep! A company tried to do something similar with sour sop and another with turmeric; copy the molecular effectiveness so it could be a new patented drug. Guessing they got close enough with the ivermectin since they were the ones to "bottle" this bacteria.

Expand full comment

Alex, what on earth?! Uttar Pradesh had way better results with Ivermectin with millions in their “study.” Why are you not covering this?

Expand full comment

Yes, cover the ivermectin story, PLEASE!!!!!

Expand full comment

I figured he was just staying in his lane all this time, but perhaps he too is being paid by someone not to look there, all this time. Alex?

Expand full comment

Wow, works almost as well as vitamin D.

Expand full comment

If it makes the Karens “feel” like husband government is taking care of then, I’m down.

Expand full comment

Yes, give those idiots anything so they will leave me and my family alone.

Expand full comment

“husband government”…so accurate 🎯

Expand full comment

Mervermectin? To compete with Pfizermectin?

Expand full comment

Ivermercktin?

Expand full comment

won't compete -- Merck makes both.

Expand full comment

Both Merck and Pfizer are developing ivermectin (IVM) clones. Simultaneously, hospitals are increasingly discouraging/forbidding IVM use, as ingestion of IVM is a disqualifier to study entry. Wonder why? I don't have a dollar amount on how much physicians earn from running studies, but it's not insubstantial. The doc who did this where I trained had a yacht parked in the Caribbean with it's own full-time staff. Docs at the local level knowingly doing this. This is sick. The Nazis would be so proud.

Expand full comment

We are all lab rats now.

Expand full comment

Seen any studies on Ivermectin? My guess it is at least as good as this new Merck drug, but vastly less expensive.

Expand full comment

But it has no association with Trump and they can make a LOT more money on it!

Expand full comment

Merck also manufactures Ivermectin but it has been around so long it is out of patent protection and relatively inexpensive.

Expand full comment

You hit the nail on the head right there!

Expand full comment

Should I list all the pharmaceutical companies I have worked for plus all those my husband has worked for? I am from NJ. All the big names there. Lived in NC as well. Again all the big guys there. They are most definitely all the same. Personnel rotates between many of them. Once upon a time, these multinationals did all of their own R&D. Now they buy into biotechs that have the promising drugs. Mostly me too drugs. Make a killing with an already approved drug now approved for another purpose. BTW, lab space in US the most corrupt and political landscape ever. Deep pockets win. So with cancer the bias is strongly slanted towards genetic origins. The metabolic folks hated and driven out. Actually ruined in some cases. Research is now not about looking where the science takes them, but about proving what deep pockets wants.

There are over 100 different chemo drugs. Think about that. Still using chemo all these years. That is NOT progress. Do you know the origins of chemo? Fascinating story. There is NO money in a cure. There is billions to be made approving drugs that barely move the needle. Do I sound cynical? I am just furious. Sick of the lies.

Expand full comment

Thanks for speaking up! Many of us from industry have known and are aware of this for so so many years. We know everything is and has been about money and more and more money and power.

Expand full comment

So health care used to be a great thing to do - including big Pharma. All you have to do is just read about the Merck story on IVM. They developed a drug and then basically gave it away. It used to be a way to make an honest buck. And do some good.

However - the government got involved. The government is the largest purchaser of drugs. CMS - the center for medicare services has a great deal of power. The field of medicine is hyper-regulated. And if you do something that is not considered main stream - you get fired or you find the FBI showing up at your office.

And vaccine development? Why are we so dependent on foreign companies? Well we didn't protect our own vaccine developers - thats why. Trial lawyers and bogus law suits put them out of business. Big Pharma moved on. Pfizer and others became large holding companies and they got rid of their research divisions.

Expand full comment

Years ago, I was very involved in IPOs for biotechs. I read so many prospectus. Burn rate. Drugs in pipeline. Clinical trials? Back then getting approval was much harder. Now vast majority fast tracked. Big pharma was once very proud of their research divisions. Democrats years ago were appalled at salaries for CEOs. By comparison of compensation today, they were quite low. So instead compensation was awarded to CEOs that pushed numbers short term to get that bonus and more stock options. Compensation packages today are ridiculous. So much higher than before democrats stuck their nose in thinking they understood compensation. The waste within big pharma is staggering.

I have worked in the oil sector, insurance, chip industry, clothing industry, retail, food industry and pharma. Software companies have high double digit margins, conversely the food industry low single digits. Look at Walmart. 3 cents made for every dollar. Pharma has margins around 25-35 percent, even higher if niche market. High margins allow much wiggle room for wages, etc. Grocery stores at 6 percent margins have little wiggle room and yet stupid public thinks all businesses have the same profit margins.

For me it is the waste that kills me. The waste at the government level is staggering. Nobody seems to care because few educated today to even notice.

The current environment with high inflation will drive more and more to poverty. It is hard assets rising in price and if you do not own any, which most do not, your purchasing power has been reduced. Just awful.

Expand full comment

So many are unaware that this shift has happened and still venerate the drug companies.

Expand full comment

Ivermectin and Molnupiravir seem to be completely unrelated drugs. Just a quick glance shows that Molnupiravir is essentially a nucleoside analog that gets incorporated during the virus transcription resulting in a mutation that inactivates the virus. It certainly sounds like it should work. It also sounds toxic.

Expand full comment

Indeed.

Expand full comment

I've started reading that this is the case.

Expand full comment

Promising…but this is just Merck’s replacement for Ivermectin. They just spent the summer shitting all over their own Nobel Prize-winning, inexpensive, widely available but off-patent Ivermectin so they could clear the path for their new, less effective, not yet safety tested but freshly patented and highly-profitable Molnupiravir.

Expand full comment

Is that the name? Someone asked me about "Ivermercktin" lol

Expand full comment

I could cry. Seriously. I might do it yet. Look, Alex. I know I don't have to give you a history lesson about Merck and the patent on Ivermectin, Merck's success with Ivermectin and its subsequent, unprovoked, national trashing of it once it started being touted as effective in stopping replication of COVID-19. And I know you are well aware of Merck's several, very expensive, failed attempts to produce a vaccine. This sidelined them. So they sought a therapeutic. Molnupiravir is a protease inhibitor which runs interference on viral replication. Ivermectin does the same. And I'd like to pit Ivermectin's track record against Molnupiravir's data any day of the week. The federal government has paid Merck $705 for each 5-day course of this new, red pill which should be good to go by the end of the year. Or until the campaign to threaten folks into being vaccinated, peters out, whichever comes first. 5 days of Ivermectin, by comparison costs about a buck. Monoclonal antibodies which also are an effective therapeutic were available a year ago. But nobody knew how to get 'em. Finally, they are here. I would not even want to venture a guess as to how many people died needlessly for want of a few tabs of Ivermectin and/or monoclonal antibody treatments. These therapeutics were held back for a reason and it doesn't take a rocket scientist to figure out why. I also remind you that the other "joke", hydroxychloroquine, is now known as a Zinc "booster" which aids in the T-cell immune response. I think now is the time for me to cry. Don't praise Merck. They would rather people die than miss an opportunity to horn in on the $billions in profits made possible by a global tragedy than give Ivermectin its due and lose out on the bonanza. Molnupiravir, this.

Expand full comment

Literally just like ivermectin. So we were denied a working therapy for 18 months so Merk can make million$

Expand full comment

Millions? You're thinking to small. More likely billions.

Expand full comment

You are not really surprised are you?

Expand full comment

Actually I'm surprised they are allowing any treatment after only pushing the vaccine down our throats

Expand full comment

At some point, it's going to be impossible to hide the fact that those "vaccines" aren't nearly as effective as they were claimed to be, then Big Pharma will need a new source of revenue.

Expand full comment

Not even a tiny bit.

Expand full comment

Street analysts are projecting $10 bil from therapeutics.

Expand full comment

You know what else they make? ivermectin 🤔

Expand full comment

Gotta know how they determined the numbers. Is that relative risk or absolute risk? Massive difference. Plus, they used the PCR test to determine these results. Yes, really. Also need to see how they screened test subjects. All of that can be seen here - https://clinicaltrials.gov/ct2/show/NCT04405739

Lest we forget, Merck is the company that gave us Vioxx, which was pulled from the market after many died from heart and strokes caused by Vioxx. There is also Gardasil with many court cases pending. Merck is a criminal enterprise just like Phizer.

Get a better return from sunshine, good diet, avoiding EMF's and toxins. All of that is much cheaper as well. https://secularheretic.substack.com/

Expand full comment

And keeping your blood glucose <99.

Expand full comment

Yup, a good diet will do that.

Expand full comment

Or you could do a meta analysis on an existing drug having had 60+ peer reviewed studies including 30 RCT's which shows even greater efficacy than Merck's product and has the additional advantages of being much cheaper and has stellar long-term safety data. I think I'll take IVM over molnupiravir, thank you.

Expand full comment